GPN Vaccines
Latest round
- Series B
Last raised
- Jun 2024
Total raised
- $18M
Investors
- 3
About GPN Vaccines
Founded in 2017 and based in Adelaide, Australia, GPN Vaccines Ltd. is a biotechnology company developing a next-generation vaccine to combat Streptococcus pneumoniae, a leading cause of pneumonia, sepsis, and other illnesses. In June 2024, GPN Vaccines Ltd. GPN Vaccines' primary product is Gamma-PN, a whole-cell vaccine designed to offer protection against all S. pneumoniae serotypes, bacteremia, and meningitis, as well as otitis media (middle ear infections). The company also offers Pfizer's Prevnar-20 to target a limited number of serotypes. The company's streamlined manufacturing process, leveraging advanced microbial fermentation and irradiation techniques, promises cost-effectiveness and scalability. As of 2023, GPN Vaccines is conducting clinical trials to evaluate the safety, tolerability, and immunogenicity of Gamma-PNTM in comparison to Prevnar 13 and Pneumovax 23.
Who invested in GPN Vaccines
3 investors across 2 rounds
See all investors in GPN Vaccines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GPN Vaccines
Who invested in GPN Vaccines?
GPN Vaccines has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GPN Vaccines raised?
GPN Vaccines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GPN Vaccines last raise money?
GPN Vaccines's most recent round on record is a Series B, in Jun 2024.
What does GPN Vaccines do?
Founded in 2017 and based in Adelaide, Australia, GPN Vaccines Ltd.
Where is GPN Vaccines headquartered?
GPN Vaccines is headquartered in Adelaide, Australia.
Which VCs invest in companies like GPN Vaccines?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Movac back biotechnology companies at GPN Vaccines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like GPN Vaccines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.